Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF versus hCG for recurrent implantation failure in intracytoplasmic sperm injection
PACTR202010482774275Not yet recruiting
- Sponsor
- Wald we bent center
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of granulocyte colony-stimulating factor and human chorionic gonadotropin in Recurrent Implantation Failure (RIF) and female infertility (2 arms), sponsored by Wald we bent center. Primary endpoint: Clinical pregnancy. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
granulocyte colony-stimulating factorhuman chorionic gonadotropin
03
Conditions
Recurrent Implantation Failure (RIF)female infertility
Beyond the preview
Go deeper on PACTR202010482774275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202010482774275.